Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients

Kosztin, Annamaria; Kutyifa, Valentina; Nagy, Vivien; Geller, Laszlo; Zima, Endre; Molnar, Levente; Szilagyi, Szabolcs; ÖZCAN, EMİN; Szeplaki, Gabor; Merkely, Bela

doi:10.1093/europace/euv117

Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients

Kosztin A., Kutyifa V., Nagy V. K., Geller L., Zima E., Molnar L., ...Daha Fazla

EUROPACE, cilt.18, sa.4, ss.550-559, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 4
Basım Tarihi: 2016
Doi Numarası: 10.1093/europace/euv117
Dergi Adı: EUROPACE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.550-559
Anahtar Kelimeler: RV-LV activation delay, Clinical response, Cardiac resynchronization therapy response
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Data on longer right to left ventricular activation delay (RV-LV AD) predicting clinical outcome after cardiac resynchronization therapy (CRT) by left bundle branch block (LBBB) are limited. We aimed to evaluate the impact of RV-LV AD on N-terminal pro-B-type natriuretic peptide (NT-proBNP), ejection fraction (EF), and clinical outcome in patients implanted with CRT, stratified by LBBB at baseline.